These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15359440)

  • 41. Antiretroviral therapy. What does the future hold?
    Johnson D
    Women Alive; 2005; ():1-2, 6. PubMed ID: 16329210
    [No Abstract]   [Full Text] [Related]  

  • 42. Regulatory issues and challenges in salvage therapy.
    Delaney M
    Res Initiat Treat Action; 2004; 10(1):29-30. PubMed ID: 15595171
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-HIV agents. Is FOTO a treatment interruption that works?
    TreatmentUpdate; 2005; 17(5):10-1. PubMed ID: 17219661
    [No Abstract]   [Full Text] [Related]  

  • 44. Getting ready for adherence.
    Wongvipat N
    Posit Living; 1999 Feb; 8(1):13-5. PubMed ID: 12492046
    [No Abstract]   [Full Text] [Related]  

  • 45. Playing with evolution requires planning.
    Richman DD; Lange JM
    Antivir Ther; 1996 Dec; 1(4):208-9. PubMed ID: 11324822
    [No Abstract]   [Full Text] [Related]  

  • 46. Cell cycles, anti-HIV drugs and treatment.
    Proj Inf Perspect; 2003 Jan; (35):18-9. PubMed ID: 12647679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A guide to using this guide.
    Berry J
    Posit Aware; 2006; 17(1):9. PubMed ID: 16475267
    [No Abstract]   [Full Text] [Related]  

  • 48. Doctors call for specialized HIV/AIDS treatment for children.
    AIDS Policy Law; 2004 Nov; 19(21):5. PubMed ID: 15614952
    [No Abstract]   [Full Text] [Related]  

  • 49. HIV infection.
    Wilkinson D; Talbot M
    Clin Evid; 2003 Dec; (10):789-98. PubMed ID: 15555122
    [No Abstract]   [Full Text] [Related]  

  • 50. HIV infection.
    Talbot M
    Clin Evid; 2004 Jun; (11):892-901. PubMed ID: 15652044
    [No Abstract]   [Full Text] [Related]  

  • 51. Switching antiretroviral therapy: why, when and how.
    Wilkin T; Glesby M; Gulick RM
    IAPAC Mon; 2006 Jul; 12(7):220-9. PubMed ID: 17096494
    [No Abstract]   [Full Text] [Related]  

  • 52. Multidrug maestro: 20 years on the trail of HIV. An interview with Martin S. Hirsch. Interview by Mark Mascolini.
    Hirsch MS
    IAPAC Mon; 2001 Apr; 7(4):104-9, 113. PubMed ID: 11700604
    [No Abstract]   [Full Text] [Related]  

  • 53. Mix and match. With as many as six drug categories, more than ever, how to treat HIV can become a matter of strategy.
    Gallant J
    Posit Aware; 2010; 21(2):18-9. PubMed ID: 20524347
    [No Abstract]   [Full Text] [Related]  

  • 54. Tales of salvage. Three men tell their story in a new era of HIV treatment.
    Vázquez E
    Posit Aware; 2007; 18(2):18-9. PubMed ID: 17390484
    [No Abstract]   [Full Text] [Related]  

  • 55. Intent-to-treat analysis.
    Kravcik S
    HIV Clin Trials; 2003; 4(6):425. PubMed ID: 14677539
    [No Abstract]   [Full Text] [Related]  

  • 56. The mixed message.
    Jones M
    Nurs Times; 1997 Aug 27-Sep 2; 93(35):22-4. PubMed ID: 9380549
    [No Abstract]   [Full Text] [Related]  

  • 57. Behind the frontline. A doctor looks at combos & side effects.
    Vázquez E
    Posit Aware; 2003; 14(1):63-4. PubMed ID: 12630377
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment. Adherence to medications key to fighting HIV/AIDS in women.
    AIDS Policy Law; 2009 Mar; 24(4):1, 4. PubMed ID: 19526627
    [No Abstract]   [Full Text] [Related]  

  • 59. TRIO study's novel combination shows promise.
    Dalton P
    Proj Inf Perspect; 2008 Sep; (46):7. PubMed ID: 19043875
    [No Abstract]   [Full Text] [Related]  

  • 60. Creating a friendly environment for your HIV medications. The effect of interactions.
    Zive JL; Learned J
    Posit Aware; 2005; Spec No():16-21. PubMed ID: 16335474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.